• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(12): e15123.
Published online Dec 31, 2010. doi:  10.1371/journal.pone.0015123
PMCID: PMC3013089

Nε−Lysine Acetylation of a Bacterial Transcription Factor Inhibits Its DNA-Binding Activity

Christophe Herman, Editor

Abstract

Evidence suggesting that eukaryotes and archaea use reversible Nε-lysine (Nε-Lys) acetylation to modulate gene expression has been reported, but evidence for bacterial use of Nε-Lys acetylation for this purpose is lacking. Here, we report data in support of the notion that bacteria can control gene expression by modulating the acetylation state of transcription factors (TFs). We screened the E. coli proteome for substrates of the bacterial Gcn5-like protein acetyltransferase (Pat). Pat acetylated four TFs, including the RcsB global regulatory protein, which controls cell division, and capsule and flagellum biosynthesis in many bacteria. Pat acetylated residue Lys180 of RcsB, and the NAD+-dependent Sir2 (sirtuin)-like protein deacetylase (CobB) deacetylated acetylated RcsB (RcsBAc), demonstrating that Nε-Lys acetylation of RcsB is reversible. Analysis of RcsBAc and variant RcsB proteins carrying substitutions at Lys180 provided biochemical and physiological evidence implicating Lys180 as a critical residue for RcsB DNA-binding activity. These findings further the likelihood that reversible Nε-Lys acetylation of transcription factors is a mode of regulation of gene expression used by all cells.

Introduction

Post-translational modification by reversible Nε-lysine (Nε-Lys) acetylation of transcription factors (TFs) and transcription-related factors such as DNA-binding proteins has been reported as a means of regulating gene expression in eukaryotes [reviewed in [1], [2]] and archaea [3], [4], but not in bacteria. The probability that Nε-Lys acetylation affects gene expression in bacteria is high for two reasons. First, Gcn5-like protein N-acetyltransferases (GNATs) [5] and NAD+-dependent Sir2-like protein deacetylases (a.k.a. sirtuins) [6], are conserved in all domains of life, and together, GNATs and sirtuins modulate the acetylation state of proteins involved in diverse cellular processes. Second, recently reported analyses of the E. coli proteome identified acetylated TFs, suggesting that Nε-Lys acetylation may directly affect gene expression in bacteria [7], [8]. Supporting experimental evidence for these findings was not reported, however. Here, we provide in vitro evidence that reversible Nε-Lys acetylation modulates the DNA-binding activity of a bacterial TF.

Among its many applications, proteome microarray technology [recently reviewed [9]] has been used to investigate post-translational modifications, including protein acetylation [10] and phosphorylation in yeast [11], and to study nucleic acid-protein interactions in E. coli [12]. Here, we used this technology to screen an E. coli proteome microarray (~4,256 proteins; [12]) for substrates of the Salmonella enterica protein acetyltransferase (Pat) enzyme, a bacterial GNAT involved in the post-translational regulation of central metabolic enzymes [13], [14], [15].

The analysis and verification of proteome microarray data suggested that Pat acetylated several bacterial TFs. Subsequent work focused on RcsB, the response regulator of a complex signal transduction system involved in diverse processes including cell division, and capsule and flagellum synthesis [reviewed in [16], [17]]. RcsB can behave as either an activator or repressor in its regulation of target genes, and can bind DNA either as a homodimer [18] or a heterodimer with accessory cofactor RcsA [19], [20]. Together, RcsB/RcsA repress the expression of the flhDC genes [21], whose products positively regulate flagellum biosynthesis genes.

Here we report biochemical and LC-MS/MS data that showed RcsB was acetylated by Pat at a single Lys residue, Lys180, which resides in the DNA-binding, helix-turn-helix (HTH) motif of the protein. Acetylation was not detected after incubation of Pat-acetylated RcsB (RcsBAc) with sirtuin deacetylase, CobB [13], [22], demonstrating reversibility. We isolated genetically encoded RcsBAc, and show that the protein lost its ability to bind DNA. By generating substitutions at Lys180 that either abolished or mimicked acetylation, we provide in vitro and in vivo evidence that further implicate Lys180 as a critical residue for RcsB-dependent repression of the flhDC genes. More specifically, mutant RcsB proteins carrying substitutions at this residue were no longer acetylated by Pat, lost their ability to bind DNA, and failed to regulate gene expression in vivo.

Results

Proteome microarray experiments reveal TFs as substrates of the Pat enzyme

To identify proteins that could be modified by the S. enterica protein acetyltranferase (Pat) enzyme, we incubated [14C, C-1]-acetyl-Coenzyme A (Ac-CoA) and Pat with an E. coli proteome microarray [12], and compared the results to a control experiment performed in parallel in the absence of Pat. Twenty-nine putative protein substrates were identified (Table S1). To validate the microarray data, we scaled up the purification of the putative protein substrates using plasmids from the ASKA library of E. coli ORFs [23], and purified proteins were individually incubated with Pat and [14C, C-1]-Ac-CoA. A schematic of the method is presented (Fig. 1A,B) along with representative results (Fig. 1C). A list of proteins confirmed to be substrates of Pat is also provided (Table S1). We validated Pat-dependent acetylation of seven proteins: MltD, RpsD, RutR, McbR, RcsB, YcjR and YbaB; four of these are reported TFs, namely, RpsD [24], McbR [25], RcsB [26], and RutR [27]. To date, Nε-Lys acetylation of these proteins has not been reported.

Figure 1
Schematic of a Pat-probed E. coli proteome microarray followed by analysis and subsequent validation.

RcsBAc is deacetylated by CobB, an NAD+-dependent sirtuin deacetylase

The CobB sirtuin is the deacetylase that, together with Pat, controls the acylation state of several metabolic proteins [14], [15], [22], [28]. To determine whether RcsBAc was a substrate of CobB, we incubated Pat-acetylated RcsB with CobB and NAD+. The results revealed that RcsBAc was a substrate of CobB, with up to 92% removal of the acetyl moiety from RcsBAc within 40 min under the conditions used (Fig. 2A–C).

Figure 2
RcsB is a substrate of the Pat acetyltransferase and CobB sirtuin deacetylase enzymes.

Pat acetylates residue Lys180 in the DNA-binding motif of the RcsB response regulator

NanoLC-MS/MS analysis of tryptic peptides representing 85% sequence coverage of RcsBAc unambiguously identified a single residue, Lys180, as the site modified by Pat (Fig. 3). Residue Lys180 is of interest because it is located within the predicted DNA-binding motif of E. coli RcsB. In spite of its location and positive charge, Lys180 in Erwinia amylovora RcsB has not been reported to make significant contacts with DNA [29]. Nevertheless, corresponding Lys residues in the DNA-recognition motif of other members of the LuxR-type family of transcription factors have been shown [e.g. Lys 179 of DosR [30]] or predicted [e.g. Lys179 of SsrB [31] and Lys41 of GerE, [32]] to make direct contacts with DNA.

Figure 3
Identification of acetylation site K180Ac on peptide SIKAcTISSQK by nanoLC-MS/MS from trypsin digests of RcsB.

Acetylation and substitutions at Lys180 cause a defect in binding of RcsB to a flhDC promoter DNA probe

We hypothesized that modifications or substitutions at Lys180 would have a negative effect on the DNA-binding activity of RcsB. To investigate this possibility, we performed electrophoretic mobility shift assays (EMSAs) using conditions similar to those reported elsewhere [21]. A DNA probe incubated with genetically encoded RcsBAc protein [obtained as described by Neumann, et al. [33], [34]; Fig. S1] lost the ability to bind DNA (Fig. 4A, bottom panel), as compared to wild-type RcsB protein (Fig. 4A, top panel). Further, single-amino acid substitutions at Lys180 (i.e. RcsBK180A, RcsBK180R, RcsBK180Q) resulted in variant proteins that had two features. One, they were not acetylated by Pat (Fig. 4B), and two, they lost DNA-binding activity as compared to wild-type RcsB tested under the same conditions (Fig. 4C). The effect of the K180Q substitution was of note since Gln substitutions have been reported to mimic Nε-LysAc [35], [36].

Figure 4
Acetylation of Lys180 inhibits RcsB DNA-binding activity, mimicking the effect of substitutions that block interactions at this position.

Since S. enterica sv. Typhimurium LT2 Pat and CobB enzymes were used in proteome microarray assays and subsequent experiments, we verified that the homologous enzymes in E. coli K-12 MG1655 also used RcsB as substrate (Fig. S2A, B). Likewise, E. coli Pat (annotated as YfiQ), also failed to acetylate variant RcsB proteins (Fig. S2C) under conditions similar to those used with the Pat enzyme, suggesting that Pat and YfiQ modify RcsB only once, at Lys180. The CobB, Pat, and RcsB proteins in these bacteria are 91%, 92%, and 99% identical, respectively. Because the pat designation has been taken for putrescine aminotransferase in E. coli K-12, we will continue to refer to the E. coli gene as yfiQ. Results from the above experiments provided confidence for subsequent experiments in E. coli.

Substitutions of Lys180 block RcsB-dependent repression of the flhDC genes

The observed loss of DNA-binding activity of RcsB (Fig. 4A,C) suggested that reversible Nε-Lys acetylation of residue Lys180 might work as a means of modulating RcsB-dependent gene expression. From the literature, we knew the Rcs system was affected by mutations in various genes, by overexpression of additional genes, or in response to environmental signals [37], [38], [39]. In E. coli, overproduction of RcsB from multicopy plasmids represses flhDC expression, with the concomitant decrease in motility [21], and activates capsule synthesis (cps), which results in mucoidy [26]. Overproduction of RcsB is believed to mimic the over-activation of the Rcs signal transduction system.

RcsB-dependent regulation of the flhDC and cps genes has been studied in vitro and in vivo [19], [21], [26]. High-level synthesis of capsular polysaccharide is inhibitory for E. coli growth, and cells have been reported to accumulate second-site mutations [26]. Because of this problem, we chose to focus on the effects from rcsB in multicopy in the context of flagellar synthesis.

To explore the effects of substitutions at Lys180 in vivo, we introduced into the cell wild-type and mutant rcsB alleles in multicopy, and determined whether the over-production of the encoded proteins would repress flhDC expression. Since variant RcsB proteins lost DNA-binding activity (Fig. 4C), we predicted that variant RcsB proteins would not repress flhDC expression in vivo. We cloned wild-type and mutant rcsB alleles under the control of arabinose-inducible promoters [40], introduced the plasmids individually into an ΔrcsB strain, and assessed motility. As previously described, expression of the rcsB+ allele repressed motility [21], in contrast, expression of the mutant rcsB alleles did not (Fig. 5A). Plasmids and strains used in these experiments are listed in table S2 and table S3, respectively.

Figure 5
Substitutions of Lys180 de-repress expression of flagellum biosynthesis genes.

To quantify the effect of substitutions at Lys180 on the expression of flhDC, we introduced plasmids that directed the synthesis of variant RcsB proteins into an ΔrcsB flhDC+ strain harboring a λ lysogen containing a PflhDC-lacZ fusion ([41], Table S3). As expected, wild-type RcsB negatively regulated flhDC expression [21] (Fig. 5B, triangles), while variant RcsB proteins did not (Fig. 5B). Western blot analysis showed that variant RcsB proteins were stable (Fig. 5C), ruling out the possibility the observed lack of flhDC repression was due to absence of RcsB.

Discussion

Our experiments revealed that both E. coli and Salmonella YfiQ/Pat enzymes modify the bacterial response regulator, RcsB, by acetylation. Likewise, the CobB sirtuin deacetylase from both bacteria modify RcsBAc by deacetylation. The site of acetylation, Lys180, appears to be critical for RcsB DNA-binding activity, as evidenced by a lack of shift in the mobility of the flhDC probe when incubated with RcsB carrying acetylation or substitutions at this position. Although Lys180 of Erwinia amylovora RcsB was not reported to make significant contacts with a DNA fragment representing the RcsA/B box [29], Lys180 is in the middle of sequence RSIK180TIS, which is proposed to be the DNA-binding HTH motif in E. amylovora RcsB [29]. This motif is conserved in E. coli RcsB, and because of its location, it is likely that acetylation at Lys180 disrupts direct interactions between E.coli RcsB and the flhDC promoter. Because of its positive charge, the molecular mechanism behind the observed loss in DNA-binding that resulted from acetylation at Lys180 is probably due to neutralization of its charge, which would disrupt or hinder direct interactions with the negatively charged phosphate backbone of DNA. This has been reported for other TFs whose DNA-binding activity was attenuated by acetylation, e.g. the mammalian TF Foxo1 [42], a member of the FOXO family of forkhead TFs.

Although RcsB-dependent regulation of genes has been investigated for the last two decades, mechanistic details of RcsB binding to DNA as a homodimer, heterodimer or in combination with accessory factors are unclear. Also missing are the mechanistic details of the effect of phosphorylation on RcsB oligomerization and/or DNA binding.

In our hands, the affinity of RcsB for the flhDC operator sequence was substantially higher than the one reported in the literature (Fig. 4A). Our data show that as low as 62 nM RcsB can exert a quantifiable effect on DNA mobility. To explain this discrepancy, we note that in vitro approaches to studying RcsB function (e.g. EMSAs, DNAse I protection assays, transcription assays) have been performed with tagged RcsB variants (maltose binding protein (MBP), His-tags) [18], [19], [20], [21], [29], [43], [44]. The use of tags is likely due to the inherent difficulty in isolating transcription factors, whose concentrations are kept low. However, the use of tag technology may be problematic since, in experiments aimed at describing RcsB binding to the flhDC operator sequence, others reported that RcsB binding to DNA was not detected unless the His-tagged RcsB concentration in the reaction mixture reached ≥1.5 µM [21].

In fact, a constitutively active form of RcsB containing a mutation at the proposed site of phosphorylation [45], His-tagged RcsBD56E, was used instead for both EMSA and DNAse I protection assays, and data reported suggested that this form was more active than wild-type RcsB [21].

Likewise, others reported having to use the His-tagged RcsBD56E variant to see protection from DNAse I digestion at another promoter, osmCp1, since neither His-tagged RcsB nor crude extract enriched in RcsB resulted in protection [46]. These authors also reported that even the His-tagged RcsBD56E variant was unable to produce a band shift in EMSA experiments. This observation was attributed to possibly an unstable protein-DNA complex unable to withstand electrophoresis. Indeed, the RcsB-DNA complex was reported to be unstable, and the role of RcsA proposed to stabilize this interaction [20], [29]. The RcsA/B dimer is also likely unstable since Wehland et al. [20] reported no detection of dimer formation from yeast two-hybrid screening and from affinity chromatography with immobilized His-tagged RcsB.

Although RcsB has not been reported to be acetylated in vivo, our findings suggest that reversible Nε-Lys acetylation may be involved in regulating E. coli cell motility (Fig. 5A,B). This observation is not unprecedented. Recent reports showed that acetylation of the E. coli response regulator CheY had a negative effect on binding to its targets [47], and that CobB was able to regulate chemotaxis by deacetylation of CheY, shown in vitro and in vivo [48]. In addition, proteins directly involved in motility, MotB and Crp, have also been reported to be acetylated [8]. However, the effect of these modifications remains unclear. Further, a recent report on the regulation of the cobB and pat genes in S. enterica showed expression to be growth rate-dependent, and evidence showed the proteins encoded by these two genes were responsible for the reversible Nε-Lys acetylation of central metabolic enzymes in this bacterium [15]. These data suggest the possibility that other protein substrates of CobB and Pat/YfiQ may be directly or indirectly involved in processes that affect motility besides CheY and RcsB.

Materials and Methods

Fabrication of E. coli proteome chips and acetylation assay

A protein microarray containing most of the E. coli K-12 MG1655 proteome was prepared as described [12]. Each protein was spotted in duplicate and calf histones H3 and H4 were used as landmarks and positive controls. A description of the proteome chip acetylation assay is available in the supporting nformation Text S1 file on the PLos One website, www.plosone.org.

Construction of the pat, rcsB and rcsA overexpression plasmids used to generate N-terminally tagged, TEV-cleavable proteins

The 2661-bp pat (formerly yfiQ) gene of Salmonella enterica sv. Typhimurium LT2 was PCR-amplified using 5′ and 3′ primers that included KpnI and HindIII sites, respectively. PCR products cut with KpnI and HindIII were ligated into pTEV plasmid pKLD66 [49], cut with same enzymes. Plasmid pKLD66 directs the synthesis of the protein of interest with an N-terminal hexahistidine-maltose-binding protein (His6-MBP) tag cleavable with tobacco etch virus (TEV) protease [50], [51]. The presence of the insert was verified by restriction enzyme analysis and DNA sequencing using BigDye® Terminator v3.1 protocols (Applied Biosystems). Sequencing reactions were resolved and analyzed at the University of Wisconsin Biotechnology Center. The resulting 9.3-kb plasmid was named pPAT8. The 651-bp rcsB and 624-bp rcsA genes were amplified from E. coli K12 MG1655, and the plasmids were constructed as described above for pPAT8. The 7.3-kb rcsB plasmid was named pRCSB6, the 7.0-kb rcsA plasmid was named pRCSA1.

Construction of plasmids overexpressing mutant alleles of rcsB

Plasmid pRCSB6 was subjected to site-directed mutagenesis using the QuikChange XL kit (Stratagene) to produce variants RcsBK180A (AAA to GCG; plasmid pRCSB19), RcsBK180R (AAA to CGT; plasmid pRCSB20), and RcsBK180Q (AAA to CAG; plasmid pRCSB10). Table S2 lists primers used to generate the rcsB alleles.

Construction of arabinose-inducible plasmids for expression of rcsB alleles

The rcsB gene was amplified from E. coli K12 MG1655 using 5′ and 3′ primers containing terminal EcoRI (along with 30 nt 5′ of the start codon) and XbaI restriction sites, respectively. PCR products were cut with EcoRI and XbaI, and were ligated into plasmid pBAD30 [40] cut with same enzymes. The presence of the insert was confirmed by DNA sequencing. The 5.6-kb rcsB plasmid was named pRCSB3. Cloning of mutant rcsB alleles encoding variant RcsBK180A, RcsBK180R and RcsBK180Q proteins was performed as described above (Table S2).

Overproduction of Pat, CobB, RcsB and RcsA proteins

S. enterica CobB protein was purified as described [14] except that plasmid pCOBB33 encoding the cobB+ gene (laboratory collection) was used. Pat, RcsB and RcsA proteins were produced from plasmids (described above), which direct the synthesis of protein with ether an N-terminal His6-maltose-binding protein (MBP) tag or a C-terminal His6-tag removable by tobacco etch virus (TEV) protease cleavage [50], [51]. A two-step histidine affinity column purification method (described below) was used to purify Pat and RcsB. RcsA was purified using just the first step since the tag was needed for stability [29], [44]. Because RcsA is degraded by Lon protease [52], we overproduced His6-MBP-RcsA in the Lon-deficient strain ER2566.

Overexpression plasmids were transformed into strain E. coli C41(DE3) yfiQ::kan+ (laboratory collection), and overnight cultures sub-cultured 1[ratio]100 into 2 L of LB containing ampicillin (150 µg/ml). Cultures were grown at 37°C with shaking to an OD600 of 0.6, induced with IPTG (1 mM), and shaken overnight at 15°C. Cells were harvested by centrifugation, and re-suspended in 20 ml of binding buffer [20 mM sodium phosphate at pH 7.5, containing NaCl (500 mM), and imidazole (20 mM)] containing lysozyme (1 mg/ml), DNAse I (25 µg/ml) and PMSF (0.5 mM). Cells were lysed by French press (2X), and clarified cell lysate was obtained after centrifugation and filtration. Samples were loaded onto a 1-ml HisTrap HP column attached to an AKTA FPLC system (GE Healthcare).

His7-TEV protease (hereafter referred as rTEV protease) was purified as described [51]. rTEV protease was added to the tagged protein at a ratio of 1[ratio]100 protease-to-protein, the mixture was incubated at room temperature for 3 hr, then dialyzed at 4°C against 20 mM sodium phosphate at pH 7.5, containing NaCl (500 mM) and TCEP (0.5 mM). An elution consisting of a linear gradient with imidazole allowed for separation of tagged and un-tagged protein. Untagged proteins were stored in HEPES buffer (50 mM, pH 7.5) containing NaCl (150 mM) and glycerol (2.7 mM), flash-frozen in liquid nitrogen and kept at −80°C.

Construction of plasmids for overexpression of the wild-type and mutant allele of rcsB for the overproduction of C-terminally tagged, TEV-cleavable proteins for EMSA analysis

To generate a homogenously acetylated RcsB construct for analysis with EMSAs, we used a two-plasmid system described by Neumann, et al. [33], [34]. This system allows for the site-specific incorporation of Nε-acetyllysine by way of an Methanosarcina barkeri acetyl-lysyl-tRNA synthetase/tRNACUA pair that responds to the amber codon. To avoid the isolation of truncated forms of RcsBAc (the construct above was N-terminally tagged), we cloned wild-type rcsB into pET-23a(+) (EMD) which produces a C-terminal His6-tagged construct. By using a 5′ primer incorporating an NdeI site and a 3′ primer incorporating an XhoI site in addition to a TEV cleavage site (5′ – CTC GAG ACC TTG GAA GTA GAG ATT CTC GTC TTT ATC TGC CGG ACT TAA – 3′) we produced a homogenous pool of RcsB protein that retained six primer derived residues ENLYFQ following rTEV cleavage. This plasmid was named pRCSB22. By incorporating an amber codon at Lys180 (AAA to TAG by site-directed mutagenesis), we produced plasmid pRCSB23 that encodes for a homogenous pool of RcsBAc (Fig. S1). Both proteins were produced and purified as described above, except E. coli C41(DE3) was used for expression, and cells were induced at an OD600 of 0.6 with 0.5 mM IPTG. Further, the amber construct was overexpressed in media, LB + spectinomycin (50 µg/ml) + kanamycin (50 µg/ml) + ampicillin (150 µg/ml), in addition to 2 mM Nε-acetyllysine (Sigma-Aldrich) + 20 mM nicotinamide at the time of induction, similar to that described [33], . Proteins encoded by these plasmids were used to assess binding activities by EMSA analysis.

Purification of proteins from the E. coli ASKA library

Of the 29 putative Pat substrates identified by the microarray experiments, 22 were isolated using the ASKA collection [23].

Plasmids from the latter were transformed into strain E. coli C41(DE3) yfiQ::kan+. Protein isolation was performed in small-scale (5 ml) or large-scale (1 L) cultures in LB containing chloramphenicol (34 µg/ml), using a Maxwell 16 System (Promega) or an FPLC system, respectively. Proteins were stored under conditions similar to those used for Pat protein unless higher salt (300 mM NaCl) and/or DTT (1 mM) were needed for stability.

Pat-dependent acetylation of RcsB proteins

Conditions optimized for acetylation of un-tagged, wild-type RcsB were used to determine whether untagged, variant RcsB proteins were substrates of Pat. Reactions were performed in duplicate. Reactions (20 µl) contained Pat (2 µM), RcsB protein (5 µM), [14C, C-1]-Ac-CoA (25 µM), and TCEP (0.5 mM). Reactions were incubated at 37°C for 2 hr, followed by quenching with 4 µl 6X SDS-PAGE loading buffer and heating at 95°C for 2 min. 12-µl of reaction (50 pmol of RcsB protein) was resolved in a 12% SDS-PA gel, dried, and phosphor image obtained after 15-min exposure using a storage phosphor screen and a Typhoon Trio Variable Mode Imager and ImageQuant v5.2 software (GE Healthcare).

Preparation and analysis of His6-RcsBAc by nanoLC-MS/MS analysis

Details pertaining to NanoLC-MS/MS analysis of peptides of His6-RcsBAc are available in the Text S1 file.

Sirtuin-dependent deacetylation of RcsBAc

The ASKA His6-Pat protein was used to facilitate its removal by HisMag beads (Novagen) from the acetylation reaction. Un-tagged, radiolabeled RcsBAc was prepared as described above. The CobB deacetylation assay has been described [13]. Deacetylation reactions (20 µl) contained CobB (0.8 µM), radiolabeled RcsBAc (2 µM), NAD+ (1 mM), and TCEP (0.5 mM) in HEPES buffer (50 mM, pH 7.5). Reactions were performed in duplicate, including a no-enzyme control. A 10-µl sample (20 pmol of RcsB) from each reaction was loaded onto a 12% SDS-PA gel. Images were obtained as described above.

Electrophoretic mobility shift assays (EMSAs)

The LightShift Chemiluminescent EMSA Kit (Pierce) was used for binding assays. A 5′-biotinylated probe encompassing the −85 to +34 nt relative to the flhDC transcription start point [21], was generated by PCR-amplification from E. coli K-12 MG1655. Reaction volumes were 20 µl consisting of 20 fmol biotinylated-flhD probe and equimolar RcsB to RcsA un-tagged wild-type or variant protein in 1X Binding buffer with 50 ng/µl Poly(dI•dC). Reactions were incubated at 28°C for 30 min, 5 µl of 5X Loading Buffer was added, and 5 fmol of probe was resolved on 15-well 6% native polyacrylamide gel. Detection of chemiluminescence and image digitization were obtained from scanning on a Typhoon Trio Variable Mode Imager.

β-galactosidase activity assays

β-Galactosidase activities were determined as described [53]. Three independent overnight cultures were grown per strain in LB containing ampicillin (150 µg/ml), sub-cultured (1[ratio]100) into 10 ml of LB containing ampicillin (150 µg/ml) and arabinose (0.5% or 33 mM) in borosilicate tubes. Cell density was monitored shortly after inoculation into stationary phase. Cultures were incubated at 37°C with shaking. At each time point, 80 µl of culture was removed and enzyme activity measured. Refer to Table S3 for strain information.

Swimming motility assays

Refer to Table S3 for strain information. For investigation of the Lys180 substitutions on the function of RcsB, three independent overnight cultures of each strain were grown in LB containing ampicillin (150 µg/ml). Swim plates contained tryptone (10 g/L), NaCl (5 g/L), Bacto agar (Difco; 0.25% w/v), ampicillin (150 µg/ml) and arabinose (0.5% or 33 mM), and were made immediately prior to use. Inoculation was performed using a sterile needle to puncture the middle of the agar plate. Plates were incubated at 28°C for 24 hr. The diameter of the zone of swimming was measured and photographed using a Fotodyne digital imaging system.

Antibody preparation and Western blot analysis

Un-tagged, RcsB protein was used to elicit rabbit polyclonal antibodies (Harlan). To determine the level of wild-type and mutant RcsB proteins produced from expression of these rcsB alleles under the control of an arabinose-inducible promoter, cells from 10-ml cultures in LB plus ampicillin (150 µg/µl) and arabinose (0.5% or 33 mM) were harvested at a cell density of OD600 of 0.6 by centrifugation, then re-suspended in 0.5 ml of HEPES buffer (50 mM, pH 7.5) containing lysozyme (1 mg/ml), DNAse I (25 µg/ml) and PMSF (0.5 mM). Cells were lysed by sonication for two 1-min intervals using a Heat Systems-Ultrasonics sonicator (Model W-10) at setting 3. Cell debris was removed by centrifugation and 10 µl of supernatant was resolved in a 12% SDS-PA gel. Binding of α-RcsB antibodies to blots was visualized using alkaline phosphatase-conjugated goat α-rabbit immunoglobulin G (ThermoFisher) and NBT/BCIP chemistry. Band intensity was measured by densitometry analysis using a Fotodyne Digital Imaging system and TotalLab v2005 software. The experiment was performed in duplicate from two independent cultures.

Supporting Information

Text S1

This file provides details of the methodology used to identify Pat substrates using an E. coli proteome chip, the validation procedures and results for all putative Pat substrates identified by the proteome chip labeling studies, the preparation of His6-RcsBAc for LC/MS/MS analysis, and the conditions for the mass spectrometry analysis.

(DOC)

Figure S1

Native-PAGE, SDS-PAGE and Western blot analysis of wild-type RcsB and site-specific acetylated RcsB. By utilizing an acetyl-lysyl-tRNA synthetase/tRNACUA pair that incorporates Nε-acetyllysine in response to the amber codon, we generated a homogenously acetylated RcsBAc construct. A. 500 ng of each protein was resolved on a 12% native polyacrylamide gel. RcsBAc (lane 2) runs faster than wild type RcsB (lane 1). This is because neutralization of the lysine residue increases overall negative charge density, which causes the protein to migrate faster. B. Western blot analysis of 500 ng of RcsBWT and RcsBAc, (lane 1 and 2, respectively). Polyclonal rabbit α-acetylated lysine antibodies (1:1,500; Calbiochem) show that the RcsBWT and RcsBAc constructs are unacetylated and acetylated, respectively. Alkaline phosphatase conjugated secondary antibodies and NBT/BCIP chemistry was utilized for visualization.

(EPS)

Figure S2

Verification of the acetyltransferase and deacetylase activities of E. coli and S. enterica Pat and CobB enzymes. Purified proteins from either E. coli (Ec) or S. enterica (Se) were assayed with wild-type E. coli RcsB and [14C, C-1]Ac-CoA to verify activities. The E. coli enzymes were isolated from the ASKA library. A. Reactions were performed in duplicate. Reactions (20 µl) contained Pat (2 µM), RcsB protein (5 µM), [14C, C-1]-Ac-CoA (25 µM), and TCEP (0.5 mM). Reactions were incubated at 37°C for 2 hr, followed by quenching with 4 µl 6X SDS-PAGE loading buffer and heating at 95°C for 2 min. A 12-µl sample (50 pmol of RcsB protein) from each quenched reaction was resolved in a 12% SDS-PA gel, and phosphor images were obtained and analyzed using a Typhoon Trio Variable Mode Imager and ImageQuant v5.2 software (GE Healthcare). B. Quantification of the amount of label removed by CobB from Pat-radiolabeled RcsBAc. Radiolabeled RcsBAc was incubated with NAD+ and CobB sirtuin deacetylase. Reactions (20 µl) contained CobB (0.8 µM), RcsBAc protein (2.0 µM), NAD+ (1 mM), and TCEP (0.5 mM). Reactions were incubated at 37°C for 20 min, followed by quenching with 4 µl 6X SDS-PAGE loading buffer and heating at 95°C for 2 min. A 12-µl sample (20 pmol of RcsB protein) from each quenched reaction was resolved in a 12% SDS-PA gel, and phosphor images were obtained. Each determination is the average of duplicate reactions. Percentages are relative to the label associated with RcsBAc in a reaction devoid of CobB. DLU, digital light units. C. Wild-type and variant RcsB proteins were incubated with EcPat and radiolabeled Ac-CoA, resolved on a denaturing polyacrylamide gel, and exposed to a phosphor screen (represented).

(EPS)

Table S1

Proteome chip assay results and verification. aStrains contain additional mutations associated with strain VH1000 = lacI lacZ pyrE+. The VH1000 = lacI lacZ pyrE+ [var phi](flhD-lacZ) strain [5] was a gift from R. Gourse (University of Wisconsin-Madison). The strain is derived from E. coli K-12 MG1655. bThe araC771::kan+ and rcsB770::kan+ alleles were obtained from the Keio collection of in-frame deletions in E. coli K-12 BW25113 strain containing a deletion in the arabinose utilization genes, ΔaraBAD567 [6]. The insertion in araC was excised as described [7] and the rcsB770::kan+ allele was introduced by phage P1-mediated transduction.

(DOC)

Table S2

rcsB plasmids and primers. aPrimers used to introduce the amino acid substitution. Nucleotide changes are underscored. bPlasmids derived from cloning vector pBAD30 [3] for in vivo analysis. cPlasmids derived from pTEV cloning vector pKLD66 [4] for overproduction and purification of products.

(DOC)

Table S3

E. coli K-12 strains used in this studya. aStrains contain additional mutations associated with strain VH1000 = lacI lacZ pyrE+. The VH1000 = lacI lacZ pyrE+ [var phi](flhD-lacZ) strain [5] was a gift from R. Gourse (University of Wisconsin-Madison). The strain is derived from E. coli K-12 MG1655.

(DOC)

Acknowledgments

We thank Grzegorz Sabat of the Mass Spectometry Facility at the University of Wisconsin Biotechnology Center for the mass spectrometry analyses. We thank Richard Gourse for the flhD::lacZ strain and Brian Fox for the plasmid used to overproduce recombinant TEV protease. We thank Jason Chin for the plasmids used to overproduce genetically encoded RcsBAc. We thank Kathy Krasny and Yu-yi Lin for technical assistance.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: USPHS R01-GM62203 to JCE-S, USPHS U54 RR 020839 to HZ, NRSA Predoctoral Fellowship F31-GM083668 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev. 2000;64:435–459. [PMC free article] [PubMed]
2. Spange S, Wagner T, Heinzel T, Kramer OH. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol. 2009;41:185–198. [PubMed]
3. Zhao K, Chai X, Marmorstein R. Structure of a Sir2 substrate, Alba, reveals a mechanism for deacetylation-induced enhancement of DNA binding. J Biol Chem. 2003;278:26071–26077. [PubMed]
4. Marsh VL, Peak-Chew SY, Bell SD. Sir2 and the acetyltransferase, Pat, regulate the archaeal chromatin protein, Alba. J Biol Chem. 2005;280:21122–21228. [PubMed]
5. Vetting MW, Carvalho LPSd, Yu M, Hegde SS, Magnet S, et al. Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys. 2005;433:212–226. [PubMed]
6. Denu JM. The Sir2 family of protein deacetylases. Curr Op Chem Biol. 2005;9:431–440. [PubMed]
7. Zhang J, Sprung R, Pei J, Tan X, Kim S, et al. Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli. Mol Cell Proteomics. 2009;8:215–225. [PMC free article] [PubMed]
8. Yu BJ, Kim JA, Moon JH, Ryu SE, Pan JG. The diversity of lysine-acetylated proteins in Escherichia coli. J Microbiol Biotechnol. 2008;18:1529–1536. [PubMed]
9. Joos T, Bachmann J. Protein microarrays: potentials and limitations. Front Biosci. 2009;14:4376–4385. [PubMed]
10. Lin YY, Lu JY, Zhang J, Walter W, Dang W, et al. Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis. Cell. 2009;136:1073–1084. [PMC free article] [PubMed]
11. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, et al. Global analysis of protein phosphorylation in yeast. Nature. 2005;438:679–684. [PubMed]
12. Chen CS, Korobkova E, Chen H, Zhu J, Jian X, et al. A proteome chip approach reveals new DNA damage recognition activities in Escherichia coli. Nat Methods. 2008;5:69–74. [PMC free article] [PubMed]
13. Starai VJ, Escalante-Semerena JC. Identification of the protein acetyltransferase (Pat) enzyme that acetylates acetyl-CoA synthetase in Salmonella enterica. J Mol Biol. 2004;340:1005–1012. [PubMed]
14. Garrity J, Gardner JG, Hawse W, Wolberger C, Escalante-Semerena JC. N-lysine propionylation controls the activity of propionyl-CoA synthetase. J Biol Chem. 2007;282:30239–30245. [PubMed]
15. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science. 2010;327:1004–1007. [PMC free article] [PubMed]
16. Majdalani N, Gottesman S. The Rcs phosphorelay: a complex signal transduction system. Annu Rev Microbiol. 2005;59:379–405. [PubMed]
17. Huang YH, Ferrieres L, Clarke DJ. The role of the Rcs phosphorelay in Enterobacteriaceae. Res Microbiol. 2006;157:206–212. [PubMed]
18. Carballes F, Bertrand C, Bouche JP, Cam K. Regulation of Escherichia coli cell division genes ftsA and ftsZ by the two-component system rcsC-rcsB. Mol Microbiol. 1999;34:442–450. [PubMed]
19. Wehland M, Bernhard F. The RcsAB box. Characterization of a new operator essential for the regulation of exopolysaccharide biosynthesis in enteric bacteria. J Biol Chem. 2000;275:7013–7020. [PubMed]
20. Wehland M, Kiecker C, Coplin DL, Kelm O, Saenger W, et al. Identification of an RcsA/RcsB recognition motif in the promoters of exopolysaccharide biosynthetic operons from Erwinia amylovora and Pantoea stewartii subspecies stewartii. J Biol Chem. 1999;274:3300–3307. [PubMed]
21. Francez-Charlot A, Laugel B, Van Gemert A, Dubarry N, Wiorowski F, et al. RcsCDB His-Asp phosphorelay system negatively regulates the flhDC operon in Escherichia coli. Mol Microbiol. 2003;49:823–832. [PubMed]
22. Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science. 2002;298:2390–2392. [PubMed]
23. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, et al. Complete set of ORF clones of Escherichia coli ASKA library (A complete set of E. coli K-12 ORF archive): Unique resources for biological research. DNA Res. 2005;12:291–299. [PubMed]
24. Torres M, Condon C, Balada JM, Squires C, Squires CL. Ribosomal protein S4 is a transcription factor with properties remarkably similar to NusA, a protein involved in both non-ribosomal and ribosomal RNA antitermination. EMBO J. 2001;20:3811–3820. [PMC free article] [PubMed]
25. Zhang XS, Garcia-Contreras R, Wood TK. Escherichia coli transcription factor YncC (McbR) regulates colanic acid and biofilm formation by repressing expression of periplasmic protein YbiM (McbA). ISME J. 2008;2:615–631. [PubMed]
26. Brill JA, Quinlan-Walshe C, Gottesman S. Fine-structure mapping and identification of two regulators of capsule synthesis in Escherichia coli K-12. J Bacteriol. 1988;170:2599–2611. [PMC free article] [PubMed]
27. Loh KD, Gyaneshwar P, Markenscoff Papadimitriou E, Fong R, Kim KS, et al. A previously undescribed pathway for pyrimidine catabolism. Proc Natl Acad Sci U S A. 2006;103:5114–5119. [PMC free article] [PubMed]
28. Smith JS, Brachmann CB, Celic I, Kenna MA, Muhammad S, et al. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci U S A. 2000;97:6658–6663. [PMC free article] [PubMed]
29. Pristovsek P, Sengupta K, Lohr F, Schafer B, von Trebra MW, et al. Structural analysis of the DNA-binding domain of the Erwinia amylovora RcsB protein and its interaction with the RcsAB box. J Biol Chem. 2003;278:17752–17759. [PubMed]
30. Wisedchaisri G, Wu M, Rice AE, Roberts DM, Sherman DR, et al. Structures of Mycobacterium tuberculosis DosR and DosR-DNA complex involved in gene activation during adaptation to hypoxic latency. J Mol Biol. 2005;354:630–641. [PubMed]
31. Carroll RK, Liao X, Morgan LK, Cicirelli EM, Li Y, et al. Structural and functional analysis of the C-terminal DNA binding domain of the Salmonella typhimurium SPI-2 response regulator SsrB. J Biol Chem. 2009;284:12008–12019. [PMC free article] [PubMed]
32. Ducros VM, Lewis RJ, Verma CS, Dodson EJ, Leonard G, et al. Crystal structure of GerE, the ultimate transcriptional regulator of spore formation in Bacillus subtilis. J Mol Biol. 2001;306:759–771. [PubMed]
33. Neumann H, Peak-Chew SY, Chin JW. Genetically encoding N(epsilon)-acetyllysine in recombinant proteins. Nat Chem Biol. 2008;4:232–234. [PubMed]
34. Neumann H, Hancock SM, Buning R, Routh A, Chapman L, et al. A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation. Mol Cell. 2009;36:153–163. [PMC free article] [PubMed]
35. Masumoto H, Hawke D, Kobayashi R, Verreault A. A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature. 2005;436:294–298. [PubMed]
36. Kim MY, Woo EM, Chong YT, Homenko DR, Kraus WL. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol Endocrinol. 2006;20:1479–1493. [PMC free article] [PubMed]
37. Fredericks CE, Shibata S, Aizawa S, Reimann SA, Wolfe AJ. Acetyl phosphate-sensitive regulation of flagellar biogenesis and capsular biosynthesis depends on the Rcs phosphorelay. Mol Microbiol. 2006;61:734–747. [PubMed]
38. Ebel W, Vaughn GJ, Peters HK, 3rd, Trempy JE. Inactivation of mdoH leads to increased expression of colanic acid capsular polysaccharide in Escherichia coli. J Bacteriol. 1997;179:6858–6861. [PMC free article] [PubMed]
39. Kelley WL, Georgopoulos C. Positive control of the two-component RcsC/B signal transduction network by DjlA: a member of the DnaJ family of molecular chaperones in Escherichia coli. Mol Microbiol. 1997;25:913–931. [PubMed]
40. Guzman LM, Belin D, Carson MJ, Beckwith J. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995;177:4121–4130. [PMC free article] [PubMed]
41. Lemke JJ, Durfee T, Gourse RL. DksA and ppGpp directly regulate transcription of the Escherichia coli flagellar cascade. Mol Microbiol. 2009;74:1368–1379. [PMC free article] [PubMed]
42. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, et al. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci U S A. 2005;102:11278–11283. [PMC free article] [PubMed]
43. Davalos-Garcia M, Conter A, Toesca I, Gutierrez C, Cam K. Regulation of osmC gene expression by the two-component system rcsB-rcsC in Escherichia coli. J Bacteriol. 2001;183:5870–5876. [PMC free article] [PubMed]
44. Kelm O, Kiecker C, Geider K, Bernhard F. Interaction of the regulator proteins RcsA and RcsB with the promoter of the operon for amylovoran biosynthesis in Erwinia amylovora. Mol Gen Genet. 1997;256:72–83. [PubMed]
45. Gupte G, Woodward C, Stout V. Isolation and characterization of rcsB mutations that affect colanic acid capsule synthesis in Escherichia coli K-12. J Bacteriol. 1997;179:4328–4335. [PMC free article] [PubMed]
46. Sturny R, Cam K, Gutierrez C, Conter A. NhaR and RcsB independently regulate the osmCp1 promoter of Escherichia coli at overlapping regulatory sites. J Bacteriol. 2003;185:4298–4304. [PMC free article] [PubMed]
47. Liarzi O, Barak R, Bronner V, Dines M, Sagi Y, et al. Acetylation represses the binding of CheY to its target proteins. Mol Microbiol. 2010;76:932–943. [PubMed]
48. Li R, Gu J, Chen YY, Xiao CL, Wang LW, et al. CobB regulates Escherichia coli chemotaxis by deacetylating the response regulator CheY. Mol Microbiol. 2010;76:1162–1174. [PMC free article] [PubMed]
49. Rocco CJ, Dennison KL, Klenchin VA, Rayment I, Escalante-Semerena JC. Construction and use of new cloning vectors for the rapid isolation of recombinant proteins from Escherichia coli. Plasmid. 2008;59:231–237. [PMC free article] [PubMed]
50. Parks TD, Leuther KK, Howard ED, Johnston SA, Dougherty WG. Release of proteins and peptides from fusion proteins using a recombinant plant virus proteinase. Anal Biochem. 1994;216:413–417. [PubMed]
51. Blommel PG, Fox BG. A combined approach to improving large-scale production of tobacco etch virus protease. Protein Expr Purif. 2007;55:53–68. [PMC free article] [PubMed]
52. Torres-Cabassa AS, Gottesman S. Capsule synthesis in Escherichia coli K-12 is regulated by proteolysis. J Bacteriol. 1987;169:981–989. [PMC free article] [PubMed]
53. Miller JH. New York: Cold Spring Harbor Laboratory; 1972. Assay of β-galactosidase. Experiments in Molecular Genetcis. Cold Spring Harbor, pp. 352–355.

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...